Anle138b ameliorates pathological phenotypes in mouse and cellular models of Huntington's disease.

Abstract excerpt

Huntington's disease (HD) is a hereditary movement disorder caused by a CAG repeat expansion in the huntingtin gene. HD is characterized by deposition of mutant huntingtin (mHTT) aggregates, and by severe neurodegeneration of the basal ganglia and neocortex. No cure is currently available, and new treatment options are urgently needed. Here, we show that the oligomer modifying molecule anle138b (INN: emrusolmin)...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Brain
• Share to Cells, Cultured